Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

In patients with manifestations of cardiovascular disease, acetylsalicylic acid (popularly known as aspirin) has been the mainstay of treatment for decades owing to its capacity to reduce the risk of ischaemic events. Accordingly, novel antithrombotic therapies have been traditionally tested on a ba...

Full description

Bibliographic Details

Published in:	Nature reviews cardiology Vol. 15; no. 8; pp. 480 - 496
Main Authors:	Capodanno, Davide, Mehran, Roxana, Valgimigli, Marco, Baber, Usman, Windecker, Stephan, Vranckx, Pascal, Dangas, George, Rollini, Fabiana, Kimura, Takeshi, Collet, Jean-Philippe, Gibson, C Michael, Steg, Philippe Gabriel, Lopes, Renato D, Gwon, Hyeon-Cheol, Storey, Robert F, Franchi, Francesco, Bhatt, Deepak L, Serruys, Patrick W, Angiolillo, Dominick J
Format:	Journal Article
Language:	English
Published:	England Nature Publishing Group 01.08.2018
Subjects:	Acids Aspirin - therapeutic use Cardiovascular disease Cardiovascular Diseases - drug therapy Cardiovascular Diseases - prevention & control Disease prevention Fibrinolytic Agents - therapeutic use Humans Stroke Stroke - drug therapy Stroke - prevention & control
ISSN:	1759-5002, 1759-5010, 1759-5010
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!